Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1982 Sep;43(3):772–777. doi: 10.1128/jvi.43.3.772-777.1982

Immunization against the polyoma virus-induced tumor-specific transplantation antigen by early region mutants of the virus.

T Dalianis, G Magnusson, Y Ito, G Klein
PMCID: PMC256187  PMID: 6292460

Abstract

To investigate the relation between the polyoma tumor-specific transplantation antigen and the virus-coded proteins, mice were immunized by inoculation of a variety of viable polyoma virus mutants and then challenged with polyoma virus-induced tumors. Two classes of early region mutants were used. One class produces a normal small T-antigen and truncated middle and large T-antigens. The second class (hr-t mutants) forms a normal large T-antigen together with N-terminal fragments of small and middle T-antigens. All mutants, transforming as well as nontransforming, induced protection against polyoma virus tumors. However, there were quantitive differences between the mutants. The finding that an hr-t mutant could induce tumor rejection suggests that full-length middle and small T-antigens are not necessary for the induction of this response. Since intact middle T-antigen is the only virus-coded protein known to associate with the plasma membrane, the possibility must be considered that the polyoma virus tumor-specific transplantation antigen consists of cellular components.

Full text

PDF
772

Images in this article

773Image
on p.773

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Law L. W. Effects of antilymphocyte serum on virus oncogenesis. Proc Soc Exp Biol Med. 1968 Jan;127(1):207–212. doi: 10.3181/00379727-127-32657. [DOI] [PubMed] [Google Scholar]
  2. Allison A. C., Taylor R. B. Observations on thymectomy and carcinogenesis. Cancer Res. 1967 Apr;27(4):703–707. [PubMed] [Google Scholar]
  3. Benjamin T. L. Host range mutants of polyoma virus. Proc Natl Acad Sci U S A. 1970 Sep;67(1):394–399. doi: 10.1073/pnas.67.1.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Deppert W., Hanke K., Henning R. Simian virus 40 T-antigen-related cell surface antigen: serological demonstration on simian virus 40-transformed monolayer cells in situ. J Virol. 1980 Aug;35(2):505–518. doi: 10.1128/jvi.35.2.505-518.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fenyö E. M., Grundner G., Klein E. Virus-associated surface antigens on L cells and Moloney lymphoma cells. J Natl Cancer Inst. 1974 Mar;52(3):743–751. doi: 10.1093/jnci/52.3.743. [DOI] [PubMed] [Google Scholar]
  6. Francke B., Eckhart W. Polyoma gene function required for viral DNA synthesis. Virology. 1973 Sep;55(1):127–135. doi: 10.1016/s0042-6822(73)81014-1. [DOI] [PubMed] [Google Scholar]
  7. Fried M., Griffin B. E., Lund E., Robberson D. L. Polyoma virus--a study of wild-type, mutant and defective DNAs. Cold Spring Harb Symp Quant Biol. 1975;39(Pt 1):45–52. doi: 10.1101/sqb.1974.039.01.009. [DOI] [PubMed] [Google Scholar]
  8. Friedmann T., Esty A., LaPorte P., Deininger P. The nucleotide sequence and genome organization of the polyoma early region: extensive nucleotide and amino acid homology with SV40. Cell. 1979 Jul;17(3):715–724. doi: 10.1016/0092-8674(79)90278-2. [DOI] [PubMed] [Google Scholar]
  9. Goldman E., Benjamin T. L. Analysis of host range of nontransforming polyoma virus mutants. Virology. 1975 Aug;66(2):372–384. doi: 10.1016/0042-6822(75)90210-x. [DOI] [PubMed] [Google Scholar]
  10. Griffin B. E., Fried M., Cowie A. Polyoma DNA: a physical map. Proc Natl Acad Sci U S A. 1974 May;71(5):2077–2081. doi: 10.1073/pnas.71.5.2077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Griffin B. E., Ito Y., Novak U., Spurr N., Dilworth S., Smolar N., Pollack R., Smith K., Rifkin D. B. Early mutants of polyoma virus (dl8 and dl23) with altered transformation properties: is polyoma virus middle T antigen a transforming gene product? Cold Spring Harb Symp Quant Biol. 1980;44(Pt 1):271–283. doi: 10.1101/sqb.1980.044.01.031. [DOI] [PubMed] [Google Scholar]
  12. Griffin B. E., Maddock C. New classes of viable deletion mutants in the early region of polyoma virus. J Virol. 1979 Sep;31(3):645–656. doi: 10.1128/jvi.31.3.645-656.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. HABEL K. Resistance of polyoma virus immune animals to transplanted polyoma tumors. Proc Soc Exp Biol Med. 1961 Apr;106:722–725. doi: 10.3181/00379727-106-26453. [DOI] [PubMed] [Google Scholar]
  14. Hattori J., Carmichael G. G., Benjamin T. L. DNA sequence alterations in Hr-t deletion mutants of polyoma virus. Cell. 1979 Mar;16(3):505–513. doi: 10.1016/0092-8674(79)90025-4. [DOI] [PubMed] [Google Scholar]
  15. Israel M. A., Martin M. A., Miyamura T., Takemoto K. K., Rifkin D., Pollack R. Phenotype of polyoma-induced hamster tumor cells lines. J Virol. 1980 Jul;35(1):252–255. doi: 10.1128/jvi.35.1.252-255.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ito Y. Polyoma virus-specific 55K protein isolated from plasma membrane of productively infected cells is virus-coded and important for cell transformation. Virology. 1979 Oct 15;98(1):261–266. doi: 10.1016/0042-6822(79)90545-2. [DOI] [PubMed] [Google Scholar]
  17. KLEIN G., KLEIN E. Antigenic properties of other experimental tumors. Cold Spring Harb Symp Quant Biol. 1962;27:463–470. doi: 10.1101/sqb.1962.027.001.044. [DOI] [PubMed] [Google Scholar]
  18. Kiessling R., Klein E., Wigzell H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol. 1975 Feb;5(2):112–117. doi: 10.1002/eji.1830050208. [DOI] [PubMed] [Google Scholar]
  19. Kuzumaki N., Ber R., More I. A., Cochran A. J., Weiner F., Klein G. Viral expression and immunogenicity of CBA mammary carcinomas and their hybrid lines with an L-cell derivative (A9HT). Eur J Cancer. 1979 Oct;15(10):1253–1261. doi: 10.1016/0014-2964(79)90251-2. [DOI] [PubMed] [Google Scholar]
  20. Kuzumaki N., More I. A., Cochran A. J., Klein G. Thirteen new mammary tumor cell lines from different mouse strains. Eur J Cancer. 1980 Sep;16(9):1181–1192. doi: 10.1016/0014-2964(80)90177-2. [DOI] [PubMed] [Google Scholar]
  21. Law L. W. Studies of the significance of tumor antigens in induction and repression of neoplastic diseases: presidential address. Cancer Res. 1969 Jan;29(1):1–21. [PubMed] [Google Scholar]
  22. MILLER J. F. INFLUENCE OF THYMECTOMY ON TUMOR INDUCTION BY POLYOMA VIRUS IN C57BL MICE. Proc Soc Exp Biol Med. 1964 Jun;116:323–327. doi: 10.3181/00379727-116-29237. [DOI] [PubMed] [Google Scholar]
  23. Magnusson G., Berg P. Construction and analysis of viable deletion mutants of polyoma virus. J Virol. 1979 Nov;32(2):523–529. doi: 10.1128/jvi.32.2.523-529.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Magnusson G., Nilsson M. G., Dilworth S. M., Smolar N. Characterization of polyoma mutants with altered middle and large T-antigens. J Virol. 1981 Sep;39(3):673–683. doi: 10.1128/jvi.39.3.673-683.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Magnusson G., Nilsson M. G. Viable polyoma virus variant with two origins of DNA replication. Virology. 1982 May;119(1):12–21. doi: 10.1016/0042-6822(82)90060-5. [DOI] [PubMed] [Google Scholar]
  26. McCance D. J. Growth and persistence of polyoma early region deletion mutants in mice. J Virol. 1981 Sep;39(3):958–962. doi: 10.1128/jvi.39.3.958-962.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. McCoy J. L., Fefer A., Glynn J. P. Comparative studies on the induction of transplantation resistance in BALB-c and C57BL-6 mice in three murine leukemia systems. Cancer Res. 1967 Oct;27(10):1743–1748. [PubMed] [Google Scholar]
  28. ROWE W. P., HARTLEY J. W., ESTES J. D., HUEBNER R. J. Studies of mouse polyoma virus infection. 1. Procedures for quantitation and detection of virus. J Exp Med. 1959 Apr 1;109(4):379–391. doi: 10.1084/jem.109.4.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Soeda E., Arrand J. R., Smolar N., Walsh J. E., Griffin B. E. Coding potential and regulatory signals of the polyoma virus genome. Nature. 1980 Jan 31;283(5746):445–453. doi: 10.1038/283445a0. [DOI] [PubMed] [Google Scholar]
  30. Treisman R., Novak U., Favaloro J., Kamen R. Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein. Nature. 1981 Aug 13;292(5824):595–600. doi: 10.1038/292595a0. [DOI] [PubMed] [Google Scholar]
  31. VANDEPUTTE M., DENYS P., Jr, LEYTEN R., DE SOMER P. The oncogenic activity of the polyoma virus in thymectomized rats. Life Sci. 1963 Jul;(7):475–478. doi: 10.1016/0024-3205(63)90135-8. [DOI] [PubMed] [Google Scholar]
  32. Vandeputte M. Antilymphocytic serum and polyoma oncogenesis in rats. Transplant Proc. 1969 Mar;1(1):100–105. [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES